Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kontseková

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Bratislavske Lekarske Listy|July 22, 1998
[Present views on interferons]P Kontsek, E Kontseková
Acta Virologica|June 2, 1998
Forty years of interferonP Kontsek, E Kontseková
Acta Virologica|February 15, 2000
Immunogenicity of interferon-alpha 2 in therapy: structural and physiological aspectsP Kontsek, H Liptáková, E Kontseková
Acta Virologica|December 24, 2010
Establishment of the cell line expressing human prion protein on PrP0/0 backgroundM Prčina, P Filipčík, E Kontseková
Acta Virologica|January 16, 2009
Chronic wasting diseaseM Prcina, J Bardon, E Kontseková
Bratislavske Lekarske Listy|August 1, 1992
[Bispecific antibodies: present status and possibile applications]E Kontseková, M Novák, P Kontsek
Immunological Investigations|August 1, 1995
Relativity of an antigenic homology between human interferon-alpha 1 and interferon-alpha 2cM Csabayová, E Kontseková, P Kontsek
Folia Biologica|January 1, 1988
Karyotype analysis of hybridomas producing monoclonal antibodies against different antigensP Kontsek, M Novák, E Kontseková
Acta Virologica|June 25, 2015
Prion protein prevents heavy metals overloading of cells and thus protects them against their toxicityM Prčina, E Kontseková, M Novák
Immunological Investigations|June 1, 1997
Different stabilities of the N- and C- terminal domains of human interferon alphaZ Skamlová, E Kontseková, P Kontsek
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Bratislavske Lekarske Listy|July 22, 1998
[Present views on interferons]P Kontsek, E Kontseková
Acta Virologica|June 2, 1998
Forty years of interferonP Kontsek, E Kontseková
Acta Virologica|February 15, 2000
Immunogenicity of interferon-alpha 2 in therapy: structural and physiological aspectsP Kontsek, H Liptáková, E Kontseková
Acta Virologica|December 24, 2010
Establishment of the cell line expressing human prion protein on PrP0/0 backgroundM Prčina, P Filipčík, E Kontseková
Acta Virologica|January 16, 2009
Chronic wasting diseaseM Prcina, J Bardon, E Kontseková
Bratislavske Lekarske Listy|August 1, 1992
[Bispecific antibodies: present status and possibile applications]E Kontseková, M Novák, P Kontsek
Immunological Investigations|August 1, 1995
Relativity of an antigenic homology between human interferon-alpha 1 and interferon-alpha 2cM Csabayová, E Kontseková, P Kontsek
Folia Biologica|January 1, 1988
Karyotype analysis of hybridomas producing monoclonal antibodies against different antigensP Kontsek, M Novák, E Kontseková
Acta Virologica|June 25, 2015
Prion protein prevents heavy metals overloading of cells and thus protects them against their toxicityM Prčina, E Kontseková, M Novák
Immunological Investigations|June 1, 1997
Different stabilities of the N- and C- terminal domains of human interferon alphaZ Skamlová, E Kontseková, P Kontsek
Pageof 4